Success Stories: EB-1A Approved for Postdoctoral Researcher in Oregon in the Field of Molecular Pharmacology
Client’s Testimonial:
This is such a great news! I'm so excited. [...] Thank you so much! I already promoted you to my friends. I'll post on public bbs when I have some time.
On September 13th, 2015, We Received another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Researcher in the Field of Molecular Pharmacology (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Oregon
Approval Notice Date: September 13th, 2015
Processing Time: 3 Months, 15 Days
In this case, the client that we had the opportunity to work with was a postdoctoral researcher from China in the field of molecular pharmacology. Specifically, our client’s research has focused on drug discovery for metabolic diseases, including liver disease, diabetes, and hypertension, as well as on the discovery of new therapeutic targets for treating both metabolic diseases and cancer. Her work had resulted in 10 peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that her case was filed, her publications had been cited at least 143 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of her work. She had also reviewed 35 manuscripts for distinctive, internationally-circulated journals. Her superior level of expertise was confirmed in the following quote from an independent recommender, “Needless to say, cancer is one of the largest problems that contemporary society today faces, creating untold personal burden as well as immense costs to the public healthcare system. Given the pressing nature of this issue, it is imperative that researchers comprising the very best of the best be put to work in the cancer battle at the biological, chemical, and pharmacological levels. I believe that [client] is such a researcher.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of molecular pharmacology, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in 3 months and 15 days.